Correction to: The impact of COVID-19 on systemic anticancer treatment delivery in Scotland.

Autor: Baxter MA; Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.; Tayside Cancer Centre, Ninewells Hospital and Medical School, NHS Tayside, Dundee, UK., Murphy J; NHS Lanarkshire, South Lanarkshire, UK., Cameron D; Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK.; Edinburgh Cancer Centre, NHS Lothian, Edinburgh, UK., Jordan J; NHS Grampian, Aberdeen, UK., Crearie C; West of Scotland Cancer Network, Glasgow, UK., Lilley C; Edinburgh Cancer Centre, NHS Lothian, Edinburgh, UK., Sadozye A; West of Scotland Cancer Network, Glasgow, UK., Maclean M; West of Scotland Cancer Network, Glasgow, UK., Hall P; Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK.; Edinburgh Cancer Centre, NHS Lothian, Edinburgh, UK., Phillips A; Tayside Cancer Centre, Ninewells Hospital and Medical School, NHS Tayside, Dundee, UK., Greger A; NHS Grampian, Aberdeen, UK., Madeleine J; NHS Highland, Inverness, UK., Petty RD; Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK. r.petty@dundee.ac.uk.; Tayside Cancer Centre, Ninewells Hospital and Medical School, NHS Tayside, Dundee, UK. r.petty@dundee.ac.uk.
Jazyk: angličtina
Zdroj: British journal of cancer [Br J Cancer] 2021 May; Vol. 124 (10), pp. 1745.
DOI: 10.1038/s41416-021-01298-w
Databáze: MEDLINE